Table 1

Table.  Drugs for Melanoma

 

 

Product

 

Class

 

Target

 

Clinical Status

 

Manufacturer

 

 

ABX-MA1

 

Antibody

 

MUC18

 

Phase I

 

Abgenix

 

Bay 43-9006

 

Small molecule

 

RAF kinase

 

Phase II

 

Bayer and Onyx

 

Canvaxin

 

Vaccine

 

Immune system

 

Phase III

 

CancerVax

Dendritic/

cancer cell fusion

 

Vaccine

 

Immune system

 

Phase II

 

Genezyme

Genasense

(Oblimersen sodium)

 

Antisense

 

Bcl-2

 

Phase III

 

 

Aventis and Genta

 

GMK

 

Vaccine

GM2 ganglioside

 

Phase III

 

Perogenics

 

MDX-010

 

Antibody

 

CTLA-4

 

Phase  II

 

Medarex

 

Vitaxin

 

Antibody

 

Integrins

 

Phase II

 

MedImmune

Melan-A/Mart-1 and gp100 melanoma

 

Gene therapy

 

Immune system

 

Phase II

 

Genzyme

 

Melaniccine

 

Vaccine

 

Immune system

 

Market

 

Corixa

 

PEG-Intron

 

Immunomodulatory

 

Immune system

 

Phase III

 

Enzon

 

Proleukin

 

Immunomodulatory

 

Immune system

 

Market

 

Chiron

 

Taxotere

 

Tubulin inhibitor

 

Microtubulin

 

Phase III

 

Aventis